Anti-HLA-DR Antibody, Rabbit Polyclonal sinobiological 100586-T08

$143.00
In stock
SKU
100586-T08
Catalog No.SizePrice (USD)
100586-T08-5050 µL$147.96
100586-T08-100100 µL$251.64
100586-T08-200200 µL$355.32

General Information

Product nameAnti-HLA-DR Antibody, Rabbit Polyclonal
Validated applicationsIHC-P (FAQ Protocol)
Species reactivityReacts with: Human
SpecificityHuman HLA-DR
ImmunogenA synthetic peptide corresponding to the center region of the Human HLA-DR
PreparationProduced in rabbits immunized with a synthetic peptide corresponding to the center region of the Human HLA-DR, and purified by antigen affinity chromatography.
SourcePolyclonal Rabbit IgG
PurificationProtein A & Antigen Affinity
Formulation0.2 μm filtered solution in PBS
ConjugateUnconjugated
FormLiquid
ShippingThis antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
StorageThis antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Image / Experimental Information

Image 1 DescriptionImmunochemical staining of human HLA-DR in human liver with rabbit polyclonal antibody (1:1000, formalin-fixed paraffin embedded sections).
Image 1 Alt TextHuman HLA-DR Immunohistochemistry(IHC) 15451
Image 1 URLSource image
Image 2 DescriptionImmunochemical staining of human HLA-DR in human liver with rabbit polyclonal antibody (1:1000, formalin-fixed paraffin embedded sections).
Image 2 Alt TextHuman HLA-DR Immunohistochemistry(IHC) 15452
Image 2 URLSource image

Background Information

DescriptionHLA-DR is a major histocompatibility complex (MHC) class II antigen presentation molecule, critical for the activation of lymphocytes and the orchestration of adaptive immune responses. HLA-DR is normally expressed on antigen-presenting cells including monocytes, macrophages, dendritic cells and B cells, but expression can be induced on epithelial cells and tumour cells in response to inflammatory conditions. MHC class II antigen presentation molecules are responsible for presentation of exogenous antigens to CD4 helper T cells. HLA-DR expression in tumours has been positively associated with enhanced lymphocytic infiltration. HLA-DR has been used as a surrogate marker of immune competence in various clinical studies, and its loss in circulation has been linked with susceptibility to post-surgical infection and sepsis.
References
  1. Dunne MR, et al. (2020) Characterising the prognostic potential of hla-dr during colorectal cancer development. Cancer Immunol Immunother 69 (8): 1577-1588.

Reviews

Write Your Own Review
You're reviewing:Anti-HLA-DR Antibody, Rabbit Polyclonal sinobiological 100586-T08
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.